Biofrontera Inc. (AI10)
Munich
Closed
Aug 21, 2026
Day's Range
0.795052 wk Range
0.7950Overview - AI10 - Biofrontera Inc.
Key Statistics
Valuation
Enterprise Value
12.51M
P/E (Trailing)
‪0.71‬
PEG Ratio
‪-0.05‬
Price / Sales (TTM)
‪0.25‬
Price / Book
‪1.79‬
EV / EBITDA
‪-2.45‬
Profitability
Gross Margin
‪79.01%‬
Profit Margin
‪-13.78%‬
Operating Margin
‪-4.36%‬
Return on Assets
‪-17.45%‬
Return on Equity
‪-988.35%‬
Ownership
Shares Outstanding
11.87M
Float
10.49M
Held by Insiders
‪11.99%‬
Held by Institutions
‪20.71%‬
Price stats
Beta
‪0.79‬
50-Day Avg
‪0.7950‬
200-Day Avg
‪0.7950‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - AI10 - Biofrontera Inc.
Peers - AI10 - Biofrontera Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Munich.
- AI10MunichBiofrontera Inc.11.80MMarket Cap+0.00%52-week change0.72P/E (Trailing)‪-13.78%‬Profit Margin
- PY3MunichGalderma Group AG42.44BMarket Cap+19.23%52-week change57.78P/E (Trailing)‪14.57%‬Profit Margin
- SH00MunichShionogi & Co., Ltd. - Unsponsored ADR13.27BMarket Cap+4.49%52-week change12.00P/E (Trailing)‪46.78%‬Profit Margin
- 0ZF0MunichGoodness Growth Holdings, Inc.336.38MMarket Cap-78.19%52-week change-3.43P/E (Trailing)‪47.28%‬Profit Margin
- AX9MunichAkebia Therapeutics Inc.255.48MMarket Cap-223.39%52-week change-47.62P/E (Trailing)‪-8.82%‬Profit Margin
- 3KFMunichAuxly Cannabis Group Inc.118.93MMarket Cap+94.33%52-week change4.51P/E (Trailing)‪57.26%‬Profit Margin
- 1KZMunichSweet Earth Holdings Corporation5.84MMarket Cap+0.00%52-week change2.49P/E (Trailing)‪57.66%‬Profit Margin
Profile Summary - AI10 - Biofrontera Inc.
About
Biofrontera Inc. is a specialty pharmaceutical company focused on the development and commercialization of dermatological products. Its primary aim is to address unmet needs in the treatment of skin diseases, with a particular emphasis on dermatology, represented by its flagship product, Ameluz. This prescription…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
